MedPath

Effect on oxidative stress and inflammation in Chronic Kidney Disease patients â?? A comparative study between two intravenous iron preparations

Phase 2
Conditions
Health Condition 1: null- Chronic kidney disease stage 4 and 5
Registration Number
CTRI/2017/12/010990
Lead Sponsor
Manipal University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Stable CKD stage 4 and 5 pre HD patients with iron deficiency anemia as per KDIGO guidelines {iron saturation (serum iron/total iron binding capacity) less than 20% or serum ferritin less than 200ng/

Exclusion Criteria

Patients with

1.Active / recent infection in the last two weeks

2.Oral or IV iron, blood transfusions received in the last two weeks.

3.Malignancy, liver disease, pregnancy, hypersensitivity to IV iron

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath